Adaptor protein function in breast cancer
Adaptor protein function in breast cancer
批准号:
10614393
负责人:
LESLIE M SHAW
金额:
$36.7万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-07 至 2024-11-30
关键词:
Adaptor Signaling ProteinAmino AcidsBasement membraneBindingBinding ProteinsBreast Cancer PatientBreast CarcinomaC-terminalCancer PatientCause of DeathCellsCytoplasmDataDiseaseDistantDistant MetastasisDockingDominant-Negative MutationGoalsIRS2 geneInsulinInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorInvadedLobular CarcinomaMalignant NeoplasmsMammary NeoplasmsMediatingMembraneMetastatic breast cancerMusMutateMutationN-terminalNeoplasm MetastasisOrganPIK3CG genePrimary NeoplasmProtein ConformationProtein-Serine-Threonine KinasesProteinsRecurrenceRoleSecondary toSignal TransductionSiteStainsStimulusStructureTailWorkblood glucose regulationbreast cancer progressionbreast cancer survivalcancer subtypesfunctional outcomesglucose uptakein vivoinsightmalignant breast neoplasmnovelnovel strategiesnovel therapeutic interventionprotein functionreceptorrecruitresponsetumortumor growth
中文摘要
项目摘要
本提案的总体目标是确定胰岛素受体底物2(IRS 2)
促进侵袭和在乳腺癌中的作用。IRS 2是一种细胞质衔接蛋白,是一种关键的信号转导蛋白。
胰岛素(IR)和胰岛素样生长因子-1(IGF 1 R)受体的效应子,两者均涉及
在乳腺癌中。缺乏Irs 2的小鼠乳腺肿瘤的转移能力显著降低
Irs 2表达升高的肿瘤具有增强的肿瘤生长和转移潜力。工作从
申请人的实验室已经确定IRS 2促进侵袭,这是转移性肿瘤扩散的早期步骤。
细胞到次级器官。IRS 2促进侵袭的重要性通过申请人最近的研究而得到加强。
发现IRS 2在多形性浸润性小叶癌(PILC)中反复突变,
转移性乳腺癌亚型重要的是,IRS 2整合上游信号以
介导其功能结果仍然未知。确定IRS 2如何调节入侵需要一个
了解它的结构,以及这种结构如何决定功能。申请人的初步资料
确定IRS 2促进侵袭的能力依赖于上游IGF 1 R/IR活化,
募集和激活PI 3 K。此外,他们在IRS 2 C-末端鉴定了一个174个氨基酸的区域,
这是入侵所必需的。重要的是,该区域不是IRS 2依赖性调节
葡萄糖摄取,揭示了IRS 2的这两种功能是独立调节的。基本互动
可能发生在这个区域内,因为它以显性负方式抑制入侵。探讨
IRS 2的结构被上游刺激物动态改变的假说,
促进必需的下游信号传导效应物的结合,申请人将:1)定义以下的结构基础:
IRS 2介导的侵袭和信号传导。IRS 2中的特定序列参与
改变蛋白质构象和信号以促进入侵的动态分子内相互作用将是
2)研究IRS 2相互作用伙伴及其在促进入侵中的作用。的假设
IRS 2内的分子内相互作用导致“无序结构域”环的形成,
信号转导子复合物介导的功能结果,这些结合蛋白之一是丝氨酸
苏氨酸激酶BMP 2K将被检测; 3)确定IRS 2依赖性侵袭在乳腺癌中的作用
体内进展。选择性靶向IRS 2依赖性侵袭的假设将揭示一个重要的
将检查这种特定功能在乳腺癌进展中的作用。IRS 2突变的贡献
PILC的进展也将被检查。
英文摘要
Project Summary
The overall goal of this proposal is to determine the mechanism by which Insulin Receptor Substrate 2 (IRS2)
promotes invasion and its role in breast cancer. IRS2 is a cytoplasmic adaptor protein that is a key signaling
effector of the insulin (IR) and insulin-like growth factor-1 (IGF1R) receptors, both of which have been implicated
in breast cancer. Mouse mammary tumors that lack Irs2 are significantly diminished in their ability to metastasize
and tumors with elevated Irs2 expression have enhanced tumor growth and metastatic potential. Work from the
applicant’s lab has established that IRS2 promotes invasion, an early step in the dissemination of metastatic
cells to secondary organs. The significance of IRS2 promoting invasion is heightened by the applicant’s recent
discovery that IRS2 is recurrently mutated in pleomorphic invasive lobular carcinoma (PILC), an aggressive,
metastatic breast cancer subtype. Importantly, the mechanism by which IRS2 integrates upstream signals to
mediate its functional outcomes remains unknown. Determining how IRS2 regulates invasion requires an
understanding of its structure, and how this structure determines function. The applicant’s preliminary data
establish that the ability of IRS2 to promote invasion is dependent upon upstream IGF1R/IR activation and the
recruitment and activation of PI3K. In addition, they identified a 174-amino acid region within the IRS2 C-terminal
tail that is required for invasion. Importantly, this region is not required for the IRS2-dependent regulation of
glucose uptake, revealing that these two functions of IRS2 are independently regulated. Essential interactions
likely occur within this region given that it acts in a dominant negative manner to inhibit invasion. To investigate
the hypothesis that the structure of IRS2 is dynamically altered by upstream stimuli that promote invasion to
facilitate binding of essential downstream signaling effectors the applicant will: 1) Define the structural basis for
IRS2-mediated invasion and signaling. The hypothesis that specific sequences within IRS2 participate in
dynamic intramolecular interactions that alter protein conformation and signaling to promote invasion will be
examined; 2) Investigate IRS2 interacting partners and their role in promoting invasion. The hypothesis that
intramolecular interactions within IRS2 lead to the formation of “disordered domain” loops that assemble distinct
signaling sub-complexes to mediate functional outcomes, and that one of these binding proteins is the serine
threonine kinase BMP2K, will be examined; 3) Establish the role of IRS2-dependent invasion in breast cancer
progression in vivo. The hypothesis that selective targeting of IRS2-dependent invasion will reveal an essential
role for this specific function in breast cancer progression will be examined. The contribution of IRS2 mutations
to PILC progression will also be examined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adaptor protein function in breast cancer
-
批准号:10355519
-
项目类别:
-
资助金额:$38.18万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin regulation of breast cancer stem cells
-
批准号:10661633
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
IRS function in breast cancer progression
-
批准号:10177899
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin regulation of breast cancer stem cells
-
批准号:10454136
-
项目类别:
-
资助金额:$16.42万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin regulation of breast cancer stem cells
-
批准号:10227661
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Adaptor protein function in breast cancer
-
批准号:10115640
-
项目类别:
-
资助金额:$39.06万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
IRS function in breast cancer progression
-
批准号:9899215
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
IRS function in breast cancer progression
-
批准号:10656330
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Adaptor protein function in breast cancer
-
批准号:9889069
-
项目类别:
-
资助金额:$38.69万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin regulation of breast cancer stem cells
-
批准号:9797802
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2019
-
负责人:LESLIE M SHAW
-
依托单位:
Autophagy-independent function of Beclin 1 in Breast Cancer
-
批准号:8592964
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:LESLIE M SHAW
-
依托单位:
Autophagy-independent function of Beclin 1 in Breast Cancer
-
批准号:8828848
-
项目类别:
-
资助金额:$5.32万
-
财政年份:2013
-
负责人:LESLIE M SHAW
-
依托单位:
Autophagy-independent function of Beclin 1 in Breast Cancer
-
批准号:8830944
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2013
-
负责人:LESLIE M SHAW
-
依托单位:
Autophagy-independent function of Beclin 1 in Breast Cancer
-
批准号:8692704
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2013
-
负责人:LESLIE M SHAW
-
依托单位:
IRS-2 Function in Tumor Progression and Metastasis
-
批准号:8259779
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2010
-
负责人:LESLIE M SHAW
-
依托单位:
IRS-2 Function in Tumor Progression and Metastasis
-
批准号:8106159
-
项目类别:
-
资助金额:$33.11万
-
财政年份:2010
-
负责人:LESLIE M SHAW
-
依托单位:
IRS-2 Function in Tumor Progression and Metastasis
-
批准号:7990262
-
项目类别:
-
资助金额:$34.13万
-
财政年份:2010
-
负责人:LESLIE M SHAW
-
依托单位:
IRS-2 Function in Tumor Progression and Metastasis
-
批准号:8462571
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2010
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin Receptor Substrate Function in Breast Cancer
-
批准号:6431130
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2002
-
负责人:LESLIE M SHAW
-
依托单位:
Insulin Receptor Substrate Function in Breast Cancer
-
批准号:6695615
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2002
-
负责人:LESLIE M SHAW
-
依托单位:
海外基金